What are the initial settings for programming a Tandem IQ (insulin pump) for a patient with diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Programming the Tandem t:slim X2 with Control-IQ: Initial Settings

To program a Tandem t:slim X2 insulin pump, you must calculate and enter four essential parameters: total daily dose (TDD), basal rate, insulin-to-carbohydrate ratio (ICR), and insulin sensitivity factor (ISF), all derived from the patient's weight and metabolic status. 1

Step 1: Calculate Total Daily Dose (TDD)

For metabolically stable patients with type 1 diabetes, start with 0.5 units/kg/day as the TDD. 1

  • Patients in the honeymoon phase require lower doses of 0.2-0.6 units/kg/day 1
  • Higher doses (>1.0 units/kg/day) are needed during puberty, pregnancy, or acute illness 1
  • For insulin-naive type 2 diabetes patients, use 0.1-0.2 units/kg/day 1

Example calculation: For a 70 kg patient with type 1 diabetes: 70 kg × 0.5 units/kg = 35 units/day TDD 1

Step 2: Program Basal Rate

Calculate the total basal dose as 0.48 × TDD (approximately 40-60% of total daily dose). 1

  • The basal rate is programmed as a constant hourly infusion over 24 hours 2
  • This rate can be adjusted throughout the day in different time blocks to account for the dawn phenomenon and daily activities 2
  • Many patients require more insulin in the morning hours when counter-regulatory hormones are elevated 2

Example: For TDD of 35 units: 35 × 0.48 = 16.8 units basal per day, which equals approximately 0.7 units/hour 1

Step 3: Calculate Insulin-to-Carbohydrate Ratio (ICR)

The ICR defines how many grams of carbohydrate are covered by 1 unit of insulin. 2

  • This ratio is calculated from the TDD and reflects the patient's insulin sensitivity 2
  • The ratio can vary throughout the day and should be set at different levels for different time blocks 2
  • A typical example ratio is 1:10, meaning 1 unit of insulin covers 10 grams of carbohydrate 2

Step 4: Calculate Insulin Sensitivity Factor (ISF)

Use the formula: ISF = 1700/TDD for rapid-acting insulin analogs. 1

  • This factor determines how much 1 unit of insulin will decrease blood glucose 2
  • For example, with a ratio of 1:3,1 unit of insulin decreases blood sugar by 3 mmol/L 2
  • The ISF is used with bolus doses to correct blood sugar above the preset target before meals 2

Example: For TDD of 35 units: 1700/35 = 49 mg/dL drop per unit of insulin 1

Step 5: Load Insulin and Prime the System

Use only rapid-acting insulin analogs (Novolog, Humalog, or Apidra) in the pump. 1

  • A 10mL vial contains 1000 units of U-100 insulin 1
  • Tubed pumps require cartridges holding 180-300 units 1
  • Patch pumps typically hold 200 units 1
  • Never dilute or mix rapid-acting insulin analogs with other insulins or solutions 1

For a patient using 35 units/day, one vial provides approximately 28 days of therapy. 1

Step 6: Set Target Glucose Range

The Control-IQ algorithm automatically adjusts insulin delivery to maintain glucose between 112.5 and 160 mg/dL. 3

  • The system predicts glucose levels 30 minutes in the future 3
  • Automatic correction boluses are delivered when glucose is predicted to rise >180 mg/dL 3
  • Overnight, the system intensifies control to achieve glucose levels of 100-120 mg/dL by morning 4

Initial Monitoring Requirements

Check blood glucose every 2-4 hours during the first 24-48 hours of pump therapy. 1

  • Adjust basal rates by 10-20% if hypoglycemia occurs 1
  • Increase basal rates by 0.1-0.2 units/hour if fasting glucose remains elevated 1
  • Reassess pump settings every 3-7 days until glycemic targets are achieved 1

Control-IQ Specific Features

The Control-IQ system automates insulin correction boluses and has a dedicated hypoglycemia safety system. 4

  • The system can suspend insulin administration when glucose is low or predicted to drop within 30 minutes 5
  • Median percent time in automation is 94.2% in real-world use 6
  • Time in range (70-180 mg/dL) improves from baseline 63.6% to 73.6% after 12 months of use 6

Critical Pitfalls to Avoid

Disconnection, occlusion, or cessation of pump therapy renders the user relatively insulin deficient within 1 hour and absolutely insulin deficient within 4 hours, with severe risk of hyperglycemia and ketosis. 2, 5

  • Only short-acting insulin is used in the pump, so there is no long-acting insulin reservoir 2
  • The cannula must be changed every 2-3 days to prevent occlusion 2, 5
  • If blood glucose exceeds 14 mmol/L (252 mg/dL), check the pump and infusion set, and test for ketones 2, 5

Ongoing Adjustments

All pump parameters should be reviewed and adjusted every 3-6 months at specialized pump therapy clinics. 2

  • Settings change with physiological factors such as weight, exercise, and menstruation 2
  • The carbohydrate-to-insulin ratio and insulin sensitivity factor require periodic recalculation 2
  • The pump's on-board calculator prevents "stacking" of insulin doses by tracking active insulin 2

References

Guideline

Insulin Pump Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Pump Therapy in Diabetes Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.